Shoulder Anterior Capsular Block and Intraarticular Steroid Injection Versus Intraarticular Steroid Injection for Enhancing Pain Relief in Adhesive Capsulitis

ConditionAnalgesia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age41-65
SponsorZagazig University

About this trial

Improving pain in the patients with adhesive capsulitis by comparing the effect of combined shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection.

Eligibility criteria

Qualifiers

Patients acceptance

Age: 41-65 years old

Sex: both sex (males or females).

Physical status: American Society of Anesthesiologist (ASA) І, II.

Disqualifiers

Shoulder pain due to secondary causes, e.g. acute trauma, fractures, bony deformity, glenohumeral joint pathology, acromioclavicular joint pathology and rotator cuff disorder.

Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)

Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone).

Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid.

Trial design

Treatments tested in this trial

  • Group Group Shoulder anterior capsular block (SHAC)
  • Group intraarticular steroid injection (IASI)

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators